Kathleen Ford
Chief Operating OfficerMs. Kathleen Ford has been Chief Operating Officer of Kura Oncology, Inc since August 12, 2019. Previously served as a consultant to us from January 2019 to August 2019. She joined Kura with biopharmaceutical experience supporting pipeline development. She was most recently Senior Vice President, Head of Global Clinical Operations, at Merck Serono, a division of Merck KGaA, where she led clinical and development operations toward successful drug registrations in both the U.S. and Europe. Previously, she served in roles of increasing responsibility at Millennium Pharmaceuticals, most recently as Vice President, Clinical Operations, where she led the global operational management of clinical trial activities in all phases of development. Prior to that, she served as Director of Clinical Operations at Alkermes, where she managed the clinical development for two product approvals. Ms. Ford earned her RN from Massachusetts General Hospital School of Nursing and her BSN from Fitchburg State College.
Positions
- Company NameKura Oncology, Inc.Stock CodeKURAPositionChief Operating OfficerColleagues
- TETroy Edward WilsonChairman, CEO & President
- BTBrian T. PowlChief Commercial Officer
- JFJennifer FulkChief Financial Officer
- TDThomas DoyleSenior Vice President of Finance & Accounting
- KMKevan M. ShokatChairman of the Scientific Advisory Board
- TRThomas Robert MalleyIndependent Director
- MTMary T. SzelaIndependent Director
- CACarol A. SchaferIndependent Director
